WallStSmart
ELAN

Elanco Animal Health

NYSE: ELAN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$21.72
-4.37% today

Updated 2026-06-05

Market cap
$12.07B
P/E ratio
P/S ratio
2.47x
EPS (TTM)
$-0.50
Dividend yield
52W range
$13 – $28
Volume
5.9M

Elanco Animal Health (ELAN) Financial statements

SEC filings — annual and quarterly data.

Profit margin
-4.92%
Operating margin
5.34%
ROE
-3.72%
ROA
1.47%
Debt/equity
0.61x

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2015$2.91B$-210.80M41.68%0.19%-7.25%
2016$2.91B$-47.90M45.78%9.72%-1.64%
2017$2.89B$-310.70M40.63%4.93%-10.75%
2018$3.07B$86.50M42.25%10.23%2.82%
2019$3.07B$67.90M45.60%12.05%2.21%
2020$3.27B$-560.10M38.09%-2.35%-17.11%
2021$4.76B$-483.00M43.58%6.38%-10.14%
2022$4.41B$-78.00M44.66%8.71%-1.77%
2023$4.42B$-1.23B43.88%7.38%-27.87%
2024$4.44B$338.00M43.01%5.65%7.61%
2025$4.71B$-232.00M43.48%5.34%-4.92%

Frequently asked questions

What is Elanco Animal Health's revenue?

Elanco Animal Health's trailing twelve-month revenue is $4.89B. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is ELAN?

In its most recent fiscal year, ELAN ran a gross margin of 43.48%, an operating margin of 5.34%, and a net margin of -4.92%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does ELAN generate?

ELAN produced $284.00M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is ELAN's balance sheet healthy?

ELAN holds $545.00M in cash and equivalents against $3.94B in long-term debt, on $6.55B of shareholder equity. That debt is best read against the cash flow the business throws off each year.